Molecule intelOpportunity: StrongEssentialCrowded market

Misoprostol

128 brands · 65 companies · product forms

ATC: A02BB01, G02AD06 1 DRAP alert

Opportunity snapshot

Launch attractiveness
50
Market saturation
96
Price room
100
Regulatory risk
50
128
brands
65
companies
Rs 209.39
median price
110
price points
100.16x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 47.65
MedianRs 209.39
Most expensiveRs 4,772.7
Spread100.16×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 100.16x across 110 trusted points (Rs 47.65-4772.7). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Misoprostol — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2022-12-22
Voluntary Recall Alert: Drug Product; Cytotol 200mcg Tablets (Batch # 176,177,178,179,180)

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(4) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

65 canonical companies and 128 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 100.16x across 110 trusted points (Rs 47.65-4772.7). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2022-12-22 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.